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LIG4 mediates Wnt signalling-induced
radioresistance
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Xi Shen1, Yoshihisa Matsumoto2, Pierre D. McCrea3,4,5, Lei Li1,4,5, Junjie Chen1,4,5 & Jae-Il Park1,4,5
Despite the implication of Wnt signalling in radioresistance, the underlying mechanisms are
unknown. Here we find that high Wnt signalling is associated with radioresistance in
colorectal cancer (CRC) cells and intestinal stem cells (ISCs). We find that LIG4, a DNA ligase
in DNA double-strand break repair, is a direct target of b-catenin. Wnt signalling enhances
non-homologous end-joining repair in CRC, which is mediated by LIG4 transactivated by
b-catenin. During radiation-induced intestinal regeneration, LIG4 mainly expressed in the
crypts is conditionally upregulated in ISCs, accompanied by Wnt/b-catenin signalling
activation. Importantly, among the DNA repair genes, LIG4 is highly upregulated in human
CRC cells, in correlation with b-catenin hyperactivation. Furthermore, blocking LIG4
sensitizes CRC cells to radiation. Our results reveal the molecular mechanism of Wnt
signalling-induced radioresistance in CRC and ISCs, and further unveils the unexpected
convergence between Wnt signalling and DNA repair pathways in tumorigenesis and tissue
regeneration.
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W
nt signalling is essential for stem cell regulation in
development and tissue homeostasis1. Wnt ligands
bind to Frizzled receptors and low-density lipoprotein
receptor-related protein 5/6 co-receptors, which stabilizes
b-catenin protein by inhibiting the protein destruction complex
composed of adenomatous polyposis coli, Axin, casein kinase 1
and glycogen synthase kinase 3. Subsequently, the stabilized
b-catenin protein is translocated into the nucleus and replaces
T-cell factor (TCF)-associated co-repressors with coactivators,
which results in the transcriptional activation of the b-catenin
target genes2.
Deregulation of Wnt/b-catenin signalling leads to human
cancers3. For example, frequent genetic mutations in Wnt
signalling components have been closely associated with human
colorectal cancer (CRC)4. In mouse models, genetic mutation
leading to the hyperactivation of Wnt signalling induced
mammary tumours and intestinal adenomas5.
Gastrointestinal tissue is often damaged by ionizing radiation
(IR) during cancer therapeutic procedures or by nuclear
accidents. Patients undergoing radiotherapy can experience
radiation-induced gastrointestinal syndrome (RIGS), which
involves death of intestinal epithelial cells (IECs) and subsequent
villous blunting and fusion6. Chronic RIGS results in intestinal
inflammation, mucosal thickening and fibrosis; acute RIGS leads
to malabsorption, electrolyte imbalance, diarrhoea, weight loss
and potential death (within 10 days of IR exposure)7.
In the intestinal epithelium, terminally differentiated IECs are
constitutively replaced by newly divided IECs from intestinal stem
cells (ISCs) located in the crypts. This biological process is tightly
controlled by Wnt signalling8. On IR treatment, cells in the crypts
undergo acute apoptosis or stop cell division. Depending on the IR
dosage, surviving clonal stem/progenitor cells regenerate the
crypts and subsequently rebuild the villi. Recently, several
reports suggested that Wnt signalling prevents IR damage in
various tissues, including the salivary gland cells9,10, mammary
gland cells11, IECs12,13, bone marrow cells14 and osteoblasts15.
Other studies have also shown that active Wnt signalling induces
radioresistance in several human cancers, including head and neck
cancer16, breast cancer17–19, nasopharyngeal cancer20, oesophageal
cancer21,22, glioblastoma23 and CRC24. However, it remains
undetermined how Wnt signalling contributes to radioresistance
in normal and cancer cells.
DNA double-strand breaks (DSBs) induce harmful lesions,
which causes cell-cycle arrest or cell death. DSBs are generated by
exogenous factors including IR or endogenously produced during
genetic recombination of immune receptor genes25. DSBs are
repaired by two major pathways: homologous recombination
(HR) and non-homologous end joining (NHEJ)26. NHEJ is the
predominant process for DSB repair. While HR is active during S
and G2 phases of the cell cycle27, NHEJ occurs throughout the
cell cycle. In the process of NHEJ, the Ku70/80 heterodimer
recognizes DSBs, as the DNA-PK complex composed of Ku70/
Ku80 and DNA-PKCS (DNA-dependent protein kinase catalytic
subunit). In association with XRCC4 (X-ray cross-complement
protein 4) and XLF (XRCC4-like factor; also called NHEJ1/
Cernunnos), DNA ligase IV (LIG4) completes DSB end joining28.
Recently, PAXX (paralogue of XRCC4 and XLF) was identified as
a new component of NHEJ process, in playing a role in
promoting Ku-dependent DNA ligation and the assembly of
core–NHEJ components29.
LIG4 is a gene that encodes ATP-dependent DNA ligase IV in
the repair of DSBs. LIG4 syndrome is caused by mutations in
LIG4 and involves reduced DNA ligase activity30. In humans,
LIG4 syndrome is characterized by radiosensitivity, microcephaly,
neurological abnormalities, bone marrow failure and increased
cancer susceptibility30. Similarly, LIG4 somatic knockout cell
lines display extreme radiosensitization31, suggesting that LIG4
is indispensable to DSB repair. Several studies showed that
mutation in LIG4 impaired the biological functions of tissue stem
cells and induced pluripotent cells32–34, indicating the essential
roles of DNA repair in the maintenance of stemness25.
Accumulating evidence suggests that tissue stem cells and
tumour-initiating cells (TICs) are relatively resistant to genotoxic
stress, which possibly contributes to the maintenance of genomic
stability; however, the mechanism of this resistance is unknown.
For example, mutation frequency is lower in embryonic stem
cells (ESCs) than in differentiated cells35,36, with increased
DNA repair activity37,38. Similarly, many studies have suggested
that TICs are resistant to genotoxic stress in various human
cancers18,39–41. Despite the implication of Wnt signalling in
radioresistance in stem cells and TICs, the molecular mechanism
remains undetermined. Here we investigated how Wnt
signalling is associated with radioresistance. Our results show that
Wnt/b-catenin signalling enhances LIG4 expression, and upregu-
lated LIG4 plays a key role in radioresistance in tissue stem cells
and cancer cells.
Results
Wnt signalling-induced radioresistance. While Wnt signalling
contributes to radioresistance in cancer, Wnt signalling activity
varies among different types of cancer, which prompted us to
hypothesize that increased Wnt signalling activity causes
increased radioresistance. To test this hypothesis, we first
isolated CRC cells based on Wnt signalling activity. We sub-
jected CRC cells to stable transduction with 7TGP, a lentivirus
encoding b-catenin green fluorescent protein (GFP) reporter42.
After viral transduction, we sorted CRC cells using fluorescence-
activated cell sorting (FACS) on the basis of GFP expression
(Fig. 1a and Supplementary Fig. 1A). By immunofluorescent
(IF) staining, we confirmed the differential expression of GFP
(GFPHigh and GFPLow; Supplementary Fig. 1B,C). Compared
with GFPLow cells, GFPHigh cells expressed relatively high levels
of b-catenin and its target genes, CD44 and CD133, mirroring
high Wnt signalling activity (Supplementary Fig. 1D–F).
Owing to the high Wnt signalling activity in colon cancer
stem cells43–47, we also investigated whether high Wnt signalling
activity is associated with increased sphere formation, an
indirect indicator of stemness. Indeed, under non-adherent
cell culture conditions, GFPHigh cells had more and larger
colonies than did GFPLow cells (Supplementary Fig. 1G,H),
indicating that GFPHigh cells possess increased cell stemness.
Next, using the GFPHigh and GFPLow CRC cells, we investigated
whether differential Wnt signalling activity is associated with
different radiosensitivity. Interestingly, cell survival assays
showed that GFPHigh HCT116 and GFPHigh SW620 cells were
more resistant to IR (4 Gy) than GFPLow cells (Fig. 1b,c). It is
noteworthy that GFPHigh cells did not show the differences in
cell proliferation, compared with GFPLow cells (Supplementary
Fig. 2), which excludes the possibility that cell proliferation
might affect cell survival on radiation treatment. Next, we
performed clonogenic cell survival assays. GFPHigh and GFPLow
HCT116 and SW620 cells were treated with IR (2, 4 and 8 Gy).
Colonies were quantified after 14 days. We found that GFPHigh
CRC cells are more resistant to IR than GFPLow cells (Fig. 1d).
Conversely, we also tested whether inhibiting Wnt signalling
sensitizes CRC cells to IR. We pretreated CRC cells with
iCRT14, a specific inhibitor of b-catenin–TCF interaction, and
subsequently exposed cells to IR. Intriguingly, iCRT14 treatment
(25 and 50 mM), sensitized CRC cells (SW620, HCT116, HT15,
COLO205, HCC2998 and KM12) to IR (Fig. 1e). Of note is that
iCRT14 per se (up to 75 mM) did not impair CRC cell
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proliferation (Supplementary Fig. 3), excluding the possibility
that iCRT14-induced cell growth inhibition affects radiosen-
sitization results. Moreover, we questioned whether iCRT14
sensitizes GFPHigh CRC cells to IR. Indeed, iCRT14-treated
GFPHigh HCT116 and GFPHigh SW620 cells became radiation-
sensitive (Supplementary Fig. 4). These results suggest that
b-catenin contributes to radioresistance in CRC cells.
LIG4 transactivation by Wnt/b-catenin signalling. Next, we
sought to understand the molecular mechanism of Wnt signal-
ling-induced radioresistance. Wnt signalling mainly controls
cellular physiology by b-catenin-mediated transactivation of Wnt
target genes. Thus, we hypothesized that b-catenin modulates
DNA repair genes. To test this hypothesis, we performed cDNA
microarrays and PCR arrays. We identified genes that were
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Figure 1 | Association of Wnt signalling and radioresistance in CRC cells. (a) CRC cell sorting by Wnt signalling activity. HCT116-7TGP cells were sorted
based on GFP expression (GFPHigh and GFPLow) by FACS. HCT116 parental cells served as a negative control for cell sorting. (b,c) Increased cell survival in
GFPHigh than GFPLow cells. HCT116-7TGP (GFPHigh and GFPLow) cells were treated with IR (4Gy). Two weeks later, cells were fixed for crystal violet staining
(b). Colony number quantification of HCT116-7TGP and SW620-7TGP cells after IR (4Gy) (c). *Po0.05. Student’s t-test; N¼ 3; error bars¼±s.e.m.
(d) Radioresistance in GFPHigh CRC cells compared with GFPLow cells. Clonogenic cell survival assay of SW620-7TGP and HCT116-7TGP cells. After IR (2, 4
and 8Gy), sorted cells (GFPHigh and GFPLow) were seeded based on plating efficiency. Two weeks later, the number of colonies was quantified. Student’s
t-test; N¼ 3; error bars¼±s.e.m. (e) Radiosensitization of CRC cells by iCRT14. CRC cells (SW620, HCT116, HT15, COLO205, HCC2998 and KM12) were
pretreated with iCRT14 (24 h) and IR (0, 2, 4 and 8Gy). Two weeks later, colonies were counted for quantification. Student’s t-test; N¼ 3; error
bars¼±s.e.m.
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upregulated with a fold change of two or greater by b-catenin
ectopic expression (cDNA microarray; gain of function) and also
downregulated by iCRT14 (PCR array; loss of function).
Of the genes involved in DNA repair pathways, we found
that LIG4 expression was upregulated by b-catenin (Fig. 2a and
Supplementary Data 1–3). Subsequent quantitative reverse
transcription–PCR (qRT–PCR) analysis results confirmed that
iCRT14 treatment significantly downregulated the transcriptional
level of LIG4 in HCT116 cells (Fig. 2b). We further confirmed
that both LIG4 and AXIN2, well-established b-catenin target
genes, were downregulated by iCRT14 in other CRC cells
(SW620, HT15, KM12 and COLO205; Fig. 2c). Conversely,
Wnt3A treatment upregulated LIG4 expression in IECs (FHC and
CCD841CoN) and 293T cells (Fig. 2d). These results suggest that
b-catenin induces LIG4 upregulation.
Next, we investigated whether b-catenin transactivates LIG4
expression. We identified seven consensus TCF-binding elements
(TBE; CTTTGA/TA/T) within 10-kb upstream of the transcrip-
tion start site of the LIG4 gene. In silico analysis using VISTA
genome browser located TBEs in conserved noncoding sequences
(CNS) of both the human and mouse LIG4 promoter (Fig. 2e),
implying that TBEs governing LIG4 transactivation might
be evolutionarily conserved in mammals. Next, we performed
chromatin immunoprecipitation (ChIP) promoter scanning. We
designed eight pairs of ChIP-PCR primers and examined whether
b-catenin and TCF3 bind to TBEs. We found that b-catenin and
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Figure 2 | LIG4 transactivation by b-catenin. (a) Identification of b-catenin target genes. DNA repair genes that are upregulated by b-catenin (465 genes)
and downregulated by iCRT14 (50mM for 24 h; 57 genes) were identified. Notably, LIG4 is both upregulated by b-catenin and downregulated by iCRT14.
Fold change4 2; Po0.005. Student’s t-test; N¼ 3. (b) Identification of NHEJ genes downregulated by b-catenin inhibition. HCT116 cells were treated with
iCRT14 (50mM for 24 h) and analyzed for expression of NHEJ repair genes using qRT-PCR. Student’s t-test; N¼ 3; error bars¼±SEM. (c) Downregulation
of LIG4 by iCRT14 in CRC cells. CRC cells (HCT116, SW620, HT15, KM12 and COLO205) were treated with iCRT14 (50 mM for 24 h) and analyzed by qRT-
PCR. AXIN2 served as a positive control for the b-catenin target gene. Student’s t-test; N¼ 3; *Po0.05; error bars¼±s.e.m. (d) Upregulation of LIG4 by
Wnt3A in IECs. Human IECs (FHC and CCD841CoN) and 293Tcells were treated with Wnt3A (200ngml 1 for 24 h) and analysed by qRT–PCR. Student’s
t-test; N¼ 3; *Po0.05; error bars¼±s.e.m. (e) LIG4 promoter analysis. Conserved noncoding sequences (CNS) found in both the mouse and human LIG4
promoter were analysed for potential TCF/LEF-binding elements (TBEs; balloons). UTR: untranslated region. (f) b-catenin transcriptional complex occupies
LIG4 promoter. HCT116 cells were analysed by ChIP assays. ChIP amplicons (1–8) were detected by ChIP-PCR. (g,h) Upregulation of LIG4 in GFPHigh cells.
SW620-7TGP CRC cells were sorted into GFPHigh and GFPLow cells, and clonally selected for semi-quantitative RT–PCR of LIG4 expression (g). ImageJ
analysis of LIG4 expression normalized by hypoxanthine phosphoribosyltransferase 1 (HPRT) (h). Student’s t-test; N¼ 3; *Po0.05; error bars¼±s.e.m.
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TCF3 co-occupy TBEs at  8,088 and  4,764 of the LIG4
promoter in HCT116 cells (Fig. 2f).
To determine whether Wnt signalling activity is associated with
the expression of LIG4, we next analysed the expression of
LIG4 in clonally selected CRC cells (GFPHigh and GFPLow
SW620-7TGP). Semi-quantitative RT–PCR showed that GFPHigh
cells express relatively higher level of LIG4, compared with that in
GFPLow cells (Fig. 2g,h). These results suggest that b-catenin
upregulates LIG4 expression in CRC cells and IECs.
LIG4 mediates Wnt signalling-induced radioresistance. With
XRCC4 and XLF, LIG4 participates in DSB repair through NHEJ.
LIG4 somatically targeted (LIG4 / ) HCT116 cells are viable
but are highly sensitive to DNA genotoxic stress31, suggesting that
LIG4 plays a crucial role in DSB repair in CRC cells. Owing to the
transactivation of LIG4 by b-catenin, we asked whether LIG4
mediates Wnt/b-catenin signalling-induced radioresistance in
CRC cells. We assessed phosphorylated gH2AX, a surrogate
marker of DNA DSBs, to determine whether gH2AX foci
formation is inversely associated with Wnt signalling activity.
We treated HCT116 cells with iCRT14 and subjected the cells to
IR (4Gy). Then, cells were subjected to IF staining for gH2AX. At
the early time point (0.5 h after IR), no difference in the DNA
damage foci formation was observed, suggesting that Wnt
signalling activity is not associated with the early stages of
DNA damage foci formation. However, at the later time point
(24 h after IR), iCRT14-treated HCT116 cells still exhibited
sustained gH2AX foci (Fig. 3a,b).
To complement this approach, we also activated Wnt/
b-catenin signalling in human IECs (FHC and CCD841CoN)
by treating the cells with Wnt3A (200 ngml 1; 24 h) and
subsequently with IR (4Gy). After 24 h, we monitored gH2AX
foci by IF staining. In contrast to the sustained gH2AX in the
iCRT14-treated CRC cells, Wnt-activated IECs had fewer gH2AX
foci than cells that were not treated with Wnt3A (Fig. 3c,d).
To further determine whether Wnt signalling-induced radio-
resistance is due to LIG4 upregulation, we used SCR7, which
inhibits LIG4 by interfering in the interaction between LIG4
and DNA48. We asked whether SCR7 treatment restores radio-
sensitization of IECs treated with Wnt3A. Indeed, SCR7
treatment increased gH2AX foci formation in CCD841CoN
cells treated with Wnt3A and subsequent IR (Fig. 3e,f).
These results suggest that Wnt signalling induces radioresis-
tance via LIG4.
Next, we used plasmid recircularization assays to examine the
effects of inhibiting Wnt signalling on NHEJ activity. Linearized
plasmids encoding tdTomato-CreERT2 (TCE)-expressing
plasmids were co-transfected with cyan fluorescent protein
(CFP)-expressing plasmids (internal control) in SW620-7TGP
GFPHigh cells treated with dimethylsulfoxide (vehicle control) or
iCRT14 (Fig. 3g). We found that iCRT14-treated SW620 GFPHigh
cells had lower tdTomato expression than the control cells
(Fig. 3h,i). These results suggest that b-catenin enhances NHEJ in
CRC cells.
We next investigated whether ectopic expression of LIG4
rescues Wnt signalling inhibition-induced defects in DSB repair.
We established HCT116 cells that stably expressed LIG4 (wild
type or R278H, a functionally inactive hypomorphic mutant)49.
These HCT116 cells were treated with iCRT14 (50 mM for 24 h
pretreatment) and IR (4Gy) for gH2AX IF staining. While the
control HCT116 cells pretreated with iCRT14 consistently
showed the sustained gH2AX foci, iCRT14-treated HCT116
cells ectopically expressing LIG4 (HCT116-LIG4) exhibited
significantly lower DNA damage foci formation (Fig. 3j,k).
However, the R278H LIG4 mutant did not rescue Wnt
signalling inhibition-induced radioresistance: these cells did not
show any decrease in gH2AX foci formation 24 h after IR
(Fig. 3j,k). Furthermore, ectopic expression of wild-type LIG4 but
not R278H mutant recovered cell survival co-treated with iCRT14
and IR (Fig. 3l). These results suggest that LIG4 mediates Wnt
signalling-induced radioresistance.
LIG4 expression in intestinal crypts. Given that Wnt/b-catenin
signaling upregulates LIG4, we further analysed the expression of
LIG4 in the small intestine, where Wnt signalling is constitutively
active for IEC replenishment. Although LIG4 is ubiquitously
expressed in IECs, we found relatively high LIG4 expression in
the intestinal crypts, where Wnt signalling is active (Fig. 4a). The
intestinal crypts contain two distinct ISCs: quiescent ISCs
(arrow), located at position 4 (þ 4), and highly proliferative crypt
base columnar (CBC) ISCs (arrowheads; Fig. 4b). In human small
intestine samples, LIG4 expression was detected in both quiescent
and proliferative ISCs and in Paneth cells, IECs residing in the
crypt bottom for secretion of anti-microbial compounds (Fig. 4c).
IF staining of mouse small intestine samples showed that LIG4
expression in both types of ISCs was slightly higher than that in
Paneth cells (Fig. 4d). qRT–PCR results further showed that Lgr5,
a marker for CBC ISCs, -expressing cells isolated from the crypts
of Lgr5CreERT2 strain displayed the higher expression of LIG4
than that in Lgr5 cells (Fig. 4e). ISCs at position 4 are quiescent
and contribute to intestinal regeneration, while CBC ISCs are
constitutively proliferative during intestinal homeostasis50,51.
However, a recent study also showed that CBC ISCs (Lgr5þ )
are indispensable for intestinal regeneration52. In addition, it was
suggested that Bmi1, a marker for quiescent ISCs, is expressed
broadly in the intestinal crypts rather than specifically in ISCs at
position 4 (ref. 53).
Owing to this complicated issue, we used a functional stem
cell marker to visualize ISCs. To make a stem cell reporter
strain, we chose the telomerase reverse transcriptase (TERT)
allele that encodes a catalytic subunit of telomerase, which is
specifically expressed in self-renewing cells. By conventional
gene targeting, we inserted the TCE cassette into the TERT
coding sequence in frame (TERTTCE knock-in strain), as
previously performed54,55 (Fig. 4f and Supplementary Figs 5
and 6). We found that TCE was specifically expressed in mouse
ESCs (Fig. 4g,h), validating TCE expression in self-renewing
cells. Of note, TCE was detected only in the cytosol in the
absence of tamoxifen, an activator of the CreERT2 fusion
protein (Supplementary Fig. 6). In mouse small intestine, TCE
was highly expressed in þ 4 ISCs and was mildly expressed in
CBC ISCs (Fig. 4i,j). Next, we analysed the expression of LIG4 in
TERTTCE mouse small intestine samples by co-IF staining. We
found that LIG4 expression is co-localized with TCE expression
(Fig. 4k). Also, qRT–PCR showed that TERTþ cells isolated
from TERTTCE exhibited the higher expression of LIG4
compared with that in TERT cells (Fig. 4l), indicating the
enrichment of LIG4 in þ 4 TERTþ ISCs.
Next, we sought to determine how Wnt-induced LIG4
expression is involved in intestinal regeneration. We treated mice
with whole-body IR (WBI, 10Gy). After 1 or 24 h, the intestines
were collected for immunohistochemistry. We observed that WBI
induced acute gH2AX foci at 1 h after WBI. After 24 h, gH2AX
foci disappeared in the crypt, whereas IECs at the crypt–villus
boundary retained gH2AX foci (Fig. 4m,n). Moreover, we
observed that CBC ISCs but not Paneth cells disappeared 24 h
after WBI (Fig. 4m; dotted arrowheads). The loss of CBC ISCs
was resulted from apoptosis, indicated by activation of caspase 3
in CBC ISCs (Fig. 4o). Moreover, 24 h after WBI, we found that
cells in position 3–4 of the crypts had started to divide (Fig. 4p;
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arrows). Interestingly, we found that WBI-induced upregulation
of LIG4 mainly occurred in these mitotic cells (Fig. 4q; arrows).
Given that b-catenin upregulates LIG4 expression, we also
asked whether WBI triggers b-catenin activation. In normal IECs,
b-catenin is mainly associated with cell adhesion through
E-cadherin. Surprisingly, after WBI, b-catenin was rapidly
localized in the cytosol in IECs and in the nucleus of IECs at
position 2–4 (Fig. 4r). We next assessed the expression of CD44, a
b-catenin target gene in crypts specifically expressed on the cell
surface of intestinal crypts. One hour after WBI, CD44 displayed
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the diffused pattern, and 24 h after WBI, CD44 was markedly
upregulated in IECs in position 3–4 but not in Paneth cells
(Fig. 4s), recapitulated by qRT–PCR of CD44 (Fig. 4t). With the
immediate loss of cell adhesion-localized b-catenin and CD44
by IR (Fig. 4r–t), we also observed the localization change of
p120-catenin, another catenin protein directly associated with the
cell adhesion (E-cadherin), into the cytosol in an IR-treated
mouse small intestine (Supplementary Fig. 7A), which led us to
test whether IR induces mislocalization of the E-cadherin, an
epithelial cell adhesion molecule. Indeed, we found the deceased
E-cadherin expression in the IR-treated mouse small intestine
(Supplementary Fig. 7B,C), which implies that the loss of
E-cadherin by IR may release b-catenin into the cytosol for
subsequent activation of LIG4. These results suggest that LIG4
upregulated by Wnt/b-catenin signalling is relatively localized in
the intestinal crypts, specifically in telomerase-expressing ISCs,
which may serve as reservoirs for intestinal progenitor cells
during intestinal regeneration on DNA damage.
Expression of LIG4 in CRC. Given that Wnt/b-catenin-induced
LIG4mediates radioresistance in CRC cells, we next examined the
expression of LIG4 in CRC. Using publicly available databases, we
assessed the expression of DSB repair-associated genes in CRC.
Interestingly, our cBioPortal database (cbioportal.org) analysis
results indicated that LIG4 is highly upregulated in CRC cells
(17% with gene amplification and mRNA upregulation). Also,
PRKDC and RAD21 showed upregulated expression in CRC
(15% for both). However, other DSB repair genes were not
upregulated or genetically altered in CRC (Fig. 5a). Similarly,
Oncomine database (oncomine.org) analysis results showed that
LIG4 expression is highly upregulated in CRC cells (1% top gene
ranked), compared with normal colon tissues (Fig. 5b).
To confirm the upregulation of LIG4 protein in CRC, we
assessed LIG4 expression in human IEC and CRC cell lines.
Consistent with in silico results, immunoblot assays showed
significant upregulation of LIG4 in all CRC cell lines, compared
with IECs (CCD841CoN) (Fig. 5c). We further analysed the
expression of LIG4 using a human CRC tissue microarray. As
observed in mouse small intestine samples (Fig. 3), we found that
human colonic crypts showed endogenous expression of LIG4 in
the nucleus (Fig. 5d). However, human colorectal adenocarci-
noma samples (N¼ 173) displayed upregulation (60.1%) of LIG4
expression, compared with normal colorectal samples (Fig. 5d).
Owing to LIG4 upregulation by b-catenin, we examined the
correlation between b-catenin and LIG4 expression in CRC TMA
samples. We found that LIG4 upregulation is correlated with
b-catenin upregulation in CRC (R¼ 0.7135; Fig. 5e). These
results suggest that LIG4 expression is highly upregulated in CRC
cells, compared with normal IECs.
Radiosensitization of CRC cells by inhibiting LIG4. Given that
LIG4 is upregulated by b-catenin and is highly upregulated in
CRC cells, we asked whether blocking LIG4 induces radio-
sensitization in CRC cells. We depleted the endogenous LIG4
using lentiviruses encoding shRNAs (Fig. 6a), then we checked
cell survival on IR. LIG4-depleted HCT116 and SW620 cells
display the decrease in cell survival on IR (Fig. 6b,c). Similarly,
pretreatment of SCR7, an inhibitor of LIG4, followed by IR (4Gy)
induced the lower survival of CRC cell lines, compared with cells
treated with IR only (Fig. 6d). Of note, SCR7 treatment per se did
not affect cell survival (Fig. 6d, lane 2). Although SCR7 was
previously shown to block tumour progression by inhibiting
NHEJ48, the impact of SCR7 on CRC cells has not been tested.
Thus, we asked whether SCR7 induces radiosensitization of CRC
cells. Clonogenic cell survival assays showed that SCR7-treated
HCT116, HT15 and SW620 CRC cells exhibited the radio-
sensitization (Fig. 6e). These results strongly suggest that
blockade of LIG4 induces radiosensitization of CRC cells.
Discussion
Wnt signalling plays key roles in radioresistance during tissue
regeneration and tumorigenesis. However, the molecular
mechanism of Wnt signalling-mediated radioresistance remains
unknown. We determined that LIG4, a key enzyme for NHEJ,
mediates Wnt signalling-induced radioresistance in CRC cells
and ISCs (Fig. 7).
We found that among the genes that participate in DSB repair,
LIG4 is upregulated by b-catenin in CRC cells and IECs. Of note,
although blocking Wnt signalling significantly downregulates
LIG4, inhibiting b-catenin does not completely suppress LIG4
expression in CRC cells (Fig. 2c). This suggests that Wnt/
b-catenin signalling enhances LIG4 expression but is not required
for basal-level expression of LIG4. This result is also supported by
our finding that LIG4 was ubiquitously expressed in IECs but was
highly enriched in the intestinal crypts where Wnt signalling is
constitutively active (Fig. 4). Consistent with these results, we also
observed that LIG4 was significantly upregulated in human CRC
cells (Fig. 5). Furthermore, we found that blocking LIG4
sensitized CRC cells to IR (Fig. 6). These results strongly suggest
that LIG4 mediates Wnt signalling-induced radioresistance in
CRC cells.
One study suggested that DSB repair is a determinant of
cellular radiosensitivity in radiation therapy. For DSB repair,
mammalian cells dominantly use NHEJ more than HR, which led
us to focus on NHEJ in Wnt signalling-controlled radioresistance.
While HR occurs in the S and G2 phases of the cell cycle, NHEJ
takes place throughout the cell cycle. Owing to the role of Wnt
signalling in promoting cell proliferation via transactivation of
CCND1 and MYC, it is plausible that Wnt signalling-induced cell
Figure 3 | LIG4 mediates Wnt signalling-induced radioresistance. (a,b) Increase of unrepaired DNA damage by Wnt signalling inhibition. HCT116 cells
were pretreated with dimethylsulfoxide (DMSO; vehicle control) or iCRT14 (50 mM for 24 h) and were treated with IR (4Gy). At each time point, cells were
collected for IF staining for phospho-gH2AX (A); quantitative analysis of DNA damage foci (b). Student’s t-test; N¼ 3; *Po0.05; error bars¼±s.e.m.;
scale bars¼ 20mm. (c,d) Decreased DNA damage foci formation by Wnt signalling. Human IECs (FHC and CCD841CoN) were pretreated with Wnt3A
(200ngml 1 for 24 h) and were subjected to IR (4Gy). After 24 h, cells were analysed for DNA damage foci formation. IF staining (c); quantitative
analysis (d). Student’s t-test; N¼ 3; *Po0.05; error bars¼±s.e.m.; scale bars¼ 20mm. (e,f) Inhibition of LIG4 blocks Wnt3A-induced radioresistance.
CCD841CoN IECs were pretreated with Wnt3A (200ngml 1 for 24h) and subjected to IR (4Gy) in the absence or presence of SCR7 (10mM); quantitative
analysis (f). Student’s t-test; N¼ 3; *Po0.05; error bars¼±s.e.m.; scale bars¼ 20mm. (g–i) Reduced NHEJ activity after Wnt signalling inhibition. SW620-
7TGP GFPHigh cells were co-transfected with linearized tdTomato-expressing plasmids (g) CMV, cytomegalovirus. Twenty-four hours after transfection, cells
were analysed by FACS (h) and were quantified (i). Student’s t-test; N¼ 3; *Po0.05; NS (not significant, PZ0.05); error bars¼±s.e.m. (j–l) LIG4 expression
rescues Wnt signalling inhibition-induced radiosensitization. iCRT14-treated HCT116 cells (control: empty vector; stably expressing wild-type (WT) LIG4 or
R278H mutant LIG4) were exposed to IR (4Gy). After 24h, cells were analysed for gH2AX foci formation; IF staining (j), statistical analysis (k) and crystal
violet staining (14 days) (l). Student’s t-test; N¼ 3; *Po0.05; NS (not significant, PZ0.05); error bars¼±s.e.m.; scale bars¼ 20mm. For b,d,f and k, the
number of phospho-gH2AX foci were counted in more than 20 nuclei from the three biological replicas.
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Figure 4 | Expression of LIG4 in the intestine. (a) Expression of LIG4 in mouse small intestine samples; IF staining. Scale bars, 50mm. (b) Illustration of
ISCs in the small intestine. ISCs located at position 4 (þ4) are indicated by arrows, and CBC ISCs are indicated by arrowheads hereafter. (c) Expression of
LIG4 in the human small intestine. 3,30-Diaminobenzidine substrate staining. (d,e) Expression of LIG4 in the crypt of the mouse small intestine. IF staining
(d) and qRT–PCR (e) of Lgr5þ and Lgr5 cells isolated from the crypts of Lgr5CreERT2 strain. AXIN2 served as a positive control for Wnt/b-catenin
signalling activity. Student’s t-test; N¼ 3; error bars¼±s.e.m.; scale bars¼ 20mm. (f) Generation of the TERTTCE strain. TCE was inserted into the TERT
allele-coding sequence in frame. (g,h) Expression of TCE in mouse ESCs. Low (g) and high (h) magnification. Scale bars¼ 100mm. (i,j) TCE expression in
the crypt of mouse small intestine samples (TERTTCE mouse). Sagittal (i) and transverse (j) sections. Scale bars¼ 20mm. (k,l) Expression of LIG4 in the
TCE-expressing cells in the crypt of mouse small intestine samples (TERTTCE mouse). IF staining (k) and qRT–PCR (l) of TERTþ cells isolated from TERTTCE.
Student’s t-test; N¼ 3; error bars¼±s.e.m.; scale bars¼ 20mm. (m,n) WBI-induced DNA damage formation. Mice were treated with WBI (10Gy;
hereafter). Notably, CBC ISCs (arrowheads) disappeared 24 h after WBI. IF staining (m); quantification of phospho-gH2AXþ cells per crypts (the number
of crypts counted Z40) (n). Student’s t-test; N¼ 3; error bars¼±s.e.m.; scale bars¼ 20mm. (o) Apoptosis of CBC cells. Samples of mouse small
intestine treated with WBI. Scale bars¼ 20mm. (p) Mitosis of IECs after WBI. Mitotic cells (arrows); haematoxylin and eosin staining. Scale bars¼ 20mm.
(q) LIG4 upregulation in mitotic cells (arrows). CBC ISCs (arrowheads). Scale bars¼ 20mm. (r) WBI-induced activation of b-catenin. Of note, WBI (10Gy)
rapidly induces b-catenin’s localization change from the cell adhesion to the cytosol and the nucleus 1 and 24h after WBI. Scale bars¼ 20mm. (s,t) CD44, a
b-catenin target gene, upregulation by WBI. One hour after WBI, CD44 expression is diffused. Twenty-four hours after WBI, CD44 expression is
considerably upregulated in IECs at transit-amplifying zone but not in Paneth cells. IF staining (s); qRT–PCR of crypts (10Gy, 24 h). Student’s t-test; N¼ 3;
error bars¼±s.e.m.; scale bars¼ 20mm. For comparative analysis, images for each figure were captured under the same exposure time. DAPI, 4,6-
diamidino-2-phenylindole.
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hyperproliferation may increase HR activity rather than NHEJ.
However, CRC cells exhibiting different Wnt signalling activity
(GFPHigh versus GFPLow) did not show significant changes in cell
proliferation (Supplementary Fig. 2). Thus, it is unlikely that the
cell proliferation is involved in Wnt signalling-controlled
radioresistance.
Intriguingly, we also observed that the expression of PRKDC
and RAD21 is highly upregulated in CRC cells (Fig. 5a). Although
these DNA repair genes are not modulated by Wnt/b-catenin
signalling, it is plausible that upregulation of these genes may also
participate in radioresistance of CRC cells, which is supported by
that the upregulation of these genes are mutually exclusive to that
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Figure 5 | Upregulation of LIG4 in CRC cells. (a) cBioPortal analysis of the expression of NHEJ repair genes in CRC cells. Compared with the other
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and CRC cell lines. (d) Upregulation of LIG4 in CRC cells. Immunostaining of human CRC tissue microarray samples for LIG4; 3,30-diaminobenzidine
substrate staining. Human colorectal adenocarcinoma samples (#1–3). Scale bars¼ 20 mm. (e) Correlation between LIG4 and b-catenin upregulation.
Immunostaining of human CRC tissue microarray for LIG4 and b-catenin (b-cat). Pearson correlation coefficient was calculated. R¼0.7135;
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of LIG4 (Fig. 5a). Therefore, our working model does not
completely exclude the involvement of additional DNA repair
genes in radioresistance of CRC cells.
In addition, it has been well established that p53 signalling
functions as a gatekeeper for the initial DNA damage response,
and via the p53 pathway. LIG4 knockout induces neurogenesis
defects and embryonic lethality56. However, our results showed
that inhibiting Wnt/b-catenin signalling induces radiosensi-
tization, independently of the p53 genetic status. For example,
blocking Wnt signalling induces radiosensitization in both the
p53 mutant cell lines (SW620, COLO205 and HCC2998) and
the p53 wild-type cell line (HCT116). Thus, our study excludes
the involvement of p53 or cell-cycle-mediated DNA repair in
Wnt signalling-mediated radioresistance in CRC cells.
Previous studies showed that Wnt signalling contributes to
radioresistance in normal IECs9,10. Our finding that Wnt/
b-catenin-mediated LIG4 transactivation induces radioresistance
reveals the molecular mechanism of radioresistance in IECs.
Interestingly, we found that LIG4 expression is relatively higher
in CBC ISCs and þ 4 ISCs to terminally differentiated IECs
(Fig. 4). Several studies suggested that þ 4 ISCs function as a
reservoir to repopulate CBC ISCs and progenitor cells during
regeneration13,50,51. Conversely, genetic cell targeting approaches
showed that Lgr5þ ISCs are indispensable for IR-induced
intestinal regeneration52. However, it should be carefully noted
that unlike nonproliferating cells such as quiescent ISCs or
terminally differentiated IECs, mitotic cells are hypersensitive to
genotoxic stress, as also observed in our results (Fig. 4o). While
þ 4 ISCs are quiescent until tissue regeneration is initiated50,
CBC ISCs are constitutively proliferative, which may account for
why CBC ISCs are hypersensitive to IR. Further studies are
needed to determine how þ 4 ISCs maintain genomic stability
and become mitotic during intestinal regeneration.
Owing to the complexity of defining ISCs53, we used our
genetically engineered mouse model to specifically visualize self-
renewing cells (TERTTCE). Importantly, we observed that LIG4 is
relatively highly expressed in telomerase-expressing cells in the
intestine, which implies that differentially expressed LIG4 may
account for how radioresistant þ 4 ISCs maintain genomic
integrity.
However, it is also noteworthy that both CBC and þ 4 ISCs
exhibit high Wnt signalling activity. Thus, additional factor(s)
may enhance or specify b-catenin-induced transactivation of
LIG4. For example, we previously found that proliferating cell
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Figure 6 | Radiosensitization of CRC cells by blockade of LIG4. (a) Depletion of endogenous LIG4 using shRNAs. HCT116 cells were stably transduced by
lentiviruses encoding shRNAs against LIG4. Immunoblot assays. (b) Inhibition of cell survival by LIG4 depletion. HCT116 and SW620 (shGFP (control) and
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bars¼±s.e.m. (c,d) Decreased colony survival of CRC cells treated with SCR7. CRC cells were treated with SCR7 (10 mM), were subjected to IR (4Gy),
and were grown for 14 days. Crystal violet staining of HCT116 cells (c) and quantification of colony survival of CRC cell lines based on optical density (d).
Student’s t-test; N¼ 3; error bars¼±s.e.m. (e) Radiosensitization by SCR7. CRC cells (HCT116, HT15 and SW620) pretreated with SCR7 (10 mM, 24 h)
were treated with IR (0, 2, 4, and 8 Gy) and analyzed by clonogenic cell survival assays. Student’s t-test; N¼ 3; error bars¼±s.e.m.
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nuclear antigen (PCNA)-associated factor (PAF), a positive
regulator of the b-catenin transcriptional complex, is specifically
expressed in þ 4 ISCs and hyperactivates Wnt/b-catenin target
gene activation57. Surprisingly, we found that LIG4 expression
was significantly upregulated in mitotic cells after IR treatment,
with overall stabilization and nuclear translocation of b-catenin
and marked upregulation of CD44 in IECs (Fig. 4q–t). Future
studies are needed to determine how IR activates Wnt/b-catenin
signalling.
Several studies have used a Wnt reporter system and shown
that Wnt signalling activity identifies CRC stem-like cells43–47.
Despite no difference in lentiviral DNA integration between
clonally selected GFPHigh (high Wnt activity) and GFPLow
(low Wnt activity) cells (Supplementary Fig. 8A), we found that
GFPHigh cells repopulate into GFPHigh and GFPLow cells, while
GFPLow cells divide into only GFPLow cells, in a separate culture
condition (Supplementary Fig. 8B). This stem cell-like property of
GFPHigh cells may be due to the (epi)genetic gene regulation or
cell plasticity. Previously, we found that PAF functions as a
cofactor of Wnt/b-catenin signalling in CRC57. Owing to
specific expression of PAF in self-renewing cells, the hetero-
genous expression of PAF may contribute to the acquisition of
stem cell-like property.
Although radiation therapy is a common cancer treatment,
radioresistance in cancer cells is still a major limitation to
overcome. To tackle this problem, we must understand the
molecular mechanism of radioresistance, which will be beneficial
for the development of a radiation sensitizer for cancer treatment.
Furthermore, given that Wnt signalling-induced radioresistance is
pivotal for tissue regeneration, understanding this mechanism
would also provide valuable knowledge that could apply to the
manipulation of tissue regeneration. Taken together, our results
show the unexpected signalling convergence between Wnt
signalling and DNA repair pathway, which holds great potential
for translation into cancer treatment and regenerative medicine.
Methods
Mammalian cell culture and materials. CRC cell lines were purchased from the
American Type Culture Collection and maintained in Dulbecco’s modified Eagle
medium (DMEM) containing 10% fetal bovine serum. CCD841CoN and FHC cells
were cultured in DMEM-F12 containing 10% fetal bovine serum. Mycoplasma
contamination was examined using MycoAlert mycoplasma detection kit (Lonza).
iCRT14 and SRC7 were purchased from Santa Cruz Biotechnology and Xcess
Biosciences, respectively. For depletion of endogenous LIG4, shLIG4 lentiviral
plasmids (GIPZ; Open Biosystems) encoding shRNA were stably transduced. Three
different LIG4 shRNAs were used (shLIG4 #1: 50-GGATGATCATAAAGGATT
T-30 ; shLIG4 #2: 50-CTATAATCCTAATACACAA-30 ; and shLIG4 #3: 50-TGG
TGTTAGTCAGCAAACT-30).
Fluorescence-activated cell sorting. CRC cell lines were subjected to stable
transduction with lentivirus encoding b-catenin reporter (7TGP; Addgene #24305).
The cells were then sorted on the basis of GFP expression using FACSCalibur
(Becton Dickinson FACSCalibur). Lgr5þ and TERTþ cells were isolated from the
crypts of each mouse strain, as previously performed57. In brief, intestines from
Lgr5CreERT2 or TTCE mouse strains were washed in ice-cold phosphate-buffered
saline (PBS) and subjected to removal of villi by scraping. To isolate Lgr5þ or
TERTþ cells, the samples were incubated with 5mM EDTA/PBS for 1 h at 4 C on
orbital shaker and followed by 10min incubation in Accutase (Thermo/21-201-
0100V) at 37 C. Single-cell suspensions were isolated through 70 mm (Biologix 15-
1070) and 40 mm nylon mesh (BD Falcon #352340). Cells were stained with Sytox
Blue(Invitrogen) for checking viability. In all, 200–500 viable EGFP
(or tdTomato)-positive and -negative cells were sorted using FACS machine
(MoFlo Astrios).
Cell proliferation assays. Fourteen days after seeding the cells, we fixed the cells
with 10% formalin and stained them with crystal violet for 30min. For cell survival
analysis, cells stained with crystal violet were subjected to lysis with 1% SDS, and
absorbance was measured at 590 nm using a 96-well microplate reader (BioTek
microplate reader).
Clonogenic cell survival assays. Clonogenic cell survival assays were performed
based on the routinely performed protocol. Briefly, before IR exposure, cells under
different conditions including iCRT14 or SCR7 treatment, or GFPHigh versus
GFPLow were trypsinized and plated (1 106 cells per plate) to the triplicated
60-mm dish. After 24 h, the number of plated cells was counted to determine
plating efficiency. On the basis of plating efficiency, the cells were plated and
counted after 24 h for the confirmation of plating efficiency values. Depending on
plating efficiency, the cells were plated to 60-mm dish and grown for 10–14 days.
Finally, cells were fixed and stained with crystal violet. Colonies containing more
than 50 cells were identified and scored as surviving colonies.
PCR arrays. Repair gene expression in CRC cells was analysed with a Human
DNA Repair RT2 Profiler PCR Array (QIAGEN).
Gene expression analysis. For RNA extraction, cells were processed using TRIzol
reagent (Invitrogen). RNA was subjected to reverse transcription using SuperScript
II (Invitrogen). Next, complementary DNA was used for gene expression analysis
using qRT–PCR. Hypoxanthine phosphoribosyltransferase 1 was used as an
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Figure 7 | Model of Wnt/radiosensitization by SCR7. In the normal intestine, LIG4 expression is upregulated in intestinal crypts, where Wnt signalling is
active. After genotoxic stress (IR), highly proliferative CBC ISCs undergo apoptosis. By an unknown mechanism, IR activates b-catenin, which leads to the
upregulation of LIG4 during intestinal regeneration.
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internal control for normalization. Fold induction was quantified using the 2-DDCT
method, as previously described57. For gene expression analysis of sorted Lgr5þ
and TERTþ cells, cDNA were generated using REPLI-g WTA Single Cell Kit
(Qiagen #150063). qRT–PCR was performed using intron-spanning primers.
Primer sequences are listed in Supplementary Table 1.
In silico promoter analysis. The CNSs were analysed using the VISTA genome
browser (http://www-gsd.lbl.gov/vista/), as previously performed54,58,59. Briefly,
human and mouse LIG4 promoter was analysed with default options (200-bp
window, x axis; 70% conservancy, y axis). If peak values (y axis) are above 50%,
such promoter region (x axis) was considered as the evolutionarily conserved
regulated elements.
ChIP assays. ChIP assays were performed using b-catenin and TCF3 antibodies
(Signal Transduction Laboratories). HCT116 cells were crosslinked with 1%
formaldehyde for 15min at room temperature. Formaldehyde was quenched by
adding glycine (final concentration, 0.125M). After washing the cells with cold
1 PBS solution, we collected the cells with lysis buffer (0.5% NP-40, 25mM
HEPES, 150mM KCl, 1.5mM MgCl2, 10% glycerol and KOH (pH 7.5)) containing
proteinase inhibitors and further incubated the cells on ice for 15min. Cell lysates
were centrifuged (5,000 r.p.m. for 5min), and supernatants were discarded. Cell
lysates were subjected to sonication with ChIP-radioimmunoprecipitation assay
lysis buffer (50mM Tris, pH 8.0; 150mM NaCl; 0.1% SDS, 0.5% deoxycholate,
1% NP-40 and 1mM EDTA; 10 times, 30 s on/30 s off) and were centrifuged
(13,200 r.p.m. for 30min). Supernatant from lysates was immunoprecipitated with
antibody overnight at 4 C and was pulled down using protein A/G PLUS-Agarose
(Santa Cruz Biotechnology) by centrifugation (3,400 r.p.m. for 2min). Immuno-
precipitates were further washed serially with ChIP-radioimmunoprecipitation
assay, high salt (50mM Tris, pH 8.0; 500mM NaCl; 0.1% SDS, 0.5% deoxycholate,
1% NP-40 and 1mM EDTA), LiCl wash buffer (50mM Tris, pH 8.0; 1mM EDTA,
250mM LiCl; 1% NP-40 and 0.5% deoxycholate) and Tris-EDTA buffer. Finally,
immunoprecipitate crosslinking was reversed by incubation at 65 C overnight, and
immunoprecipitates were treated with RNase A and proteinase K to extract
DNA. ChIP amplicons (1–8) were detected via ChIP-PCR. Primer sequences for
ChIP-PCR are available in Supplementary Data 4.
Establishment of TERTTCE genetically engineered mouse model. As previously
described54, a conventional gene targeting method was employed to generate the
TERTTCE mouse model. As described in Supplementary Fig. 6, a targeting
vector containing 50 and 30 homology arms for the TERT allele, the TCE cassette,
the PGK-Neo positive selection cassette flanked by flippase recognition target
(FRT) and the diphtheria toxin A (DTA) negative selection cassette was
constructed. Then, the linearized targeting vector was electroporated into G4
mouse ESCs. After G418 selection, correctly targeted clones were identified by
genotyping the 50 and 30 homology arms. Subsequently, targeted mouse ESCs were
injected into blastocysts to generate chimeric mice that were further bred with the
C57BL/6J strain for germ line transmission. Next, the G418 selection cassette was
removed by the FLPeR deleter strain. Lgr5CreERT2 strain was purchased from The
Jackson Laboratories (008875). Lgr5þ cells were isolated from the crypts using
FACS. Both male and female mice older than 4 weeks were used for experiments.
All mice were treated in compliance with IACUC guideline of MD Anderson
Cancer Center.
cBioPortal and Oncomine database analysis. LIG4 expression in CRC cells was
analysed in the cBioPortal (www.cbioportal.org) and Oncomine (www.oncomi-
ne.org) databases, as previously described57. cBioPortal analysis was performed
with default options using TCGA (2012) data sets for gene alterations (mutations
and copy number change) and gene expression (RNA-Seq reads per kilobase
million (RPKM)). For Oncomine analysis, the following options were chosen for
analysis: Po0.05; gene rank o1%; and fold change 42.
Immunofluorescent staining. Cells were fixed with 4% paraformaldehyde and
were immunostained according to standard protocols: the cells were blocked and
incubated with primary and fluorescence-conjugated secondary antibodies: LIG4
(Sigma (HPA001334); 1:250 dilution), and phospho-gH2AX (Cell Signaling
(20E3); 1:250 dilution). The cells were stained with 4,6-diamidino-2-phenylindole.
Cells that expressed phospho-gH2AX were examined with a fluorescent microscope
(Zeiss). DSB foci were quantified using AxioVision software. Representative images
are shown. For comparison, images were captured under the same exposure time.
Immunohistochemistry. Mouse intestinal tissue samples were collected and fixed
in 10% formalin and were processed for paraffin embedding. Sectioned samples
were immunostained according to standard protocols: samples were deparaffinized,
blocked and incubated with primary, and fluorescence- or horseradish peroxidase
(HRP)-conjugated secondary antibodies. For HRP-conjugated secondary antibody,
3,3’-Diaminobenzidine substrate was used, followed by haematoxylin nuclear
counterstaining. Antibodies against the following were used for
immunohistochemistry: LIG4 (Sigma (HPA001334); 1:250 dilution); phospho-
gH2AX (Cell Signaling (20E3); 1:250 dilution); RFP (Thermo (RF5R); 1:250
dilution); cleaved caspase 3 (Cell Signaling (5A1E); 1:500 dilution); b-catenin (Cell
Signaling (D10A8); 1:500 dilution); CD44 (BD Pharmingen (G44-26); 1:250 dilu-
tion); and CD133 (eBioscience (13A4); 1:200 dilution). Immunostained tissues were
photographed using a dissection microscope (Zeiss; AxioVision). For comparison,
images were captured with the same exposure time. CRC tissue microarray slides
were purchased from Biomax (Co2086).
Immunoblotting assays. Whole-cell lysates were prepared using NP-40 lysis
buffer (0.5% NP-40, 1.5mM MgCl2, 25mM HEPES, 150mM KCl, 10% glycerol,
1mM phenylmethylsulfonyl fluoride, 12.7mM benzamidine HCl, 0.2mM
aprotinin, 0.5mM leupeptin and 0.1mM pepstatin A) for 20min at 4 C followed
by centrifugation (14,000 r.p.m. for 10min). Supernatants were denatured in
5 SDS sample buffer (200mM Tris-HCl, pH 6.8, 40% glycerol, 8% SDS, 200mM
dithiothreitol and 0.08% bromophenol blue) at 95 C for 5min followed by
SDS–polyacrylamide gel electrophoresis. For immunoblot blocking and antibody
incubation, 0.1% non-fat dry milk in Tris-buffered saline and Tween-20 (25mM
Tris-HCl, pH 8.0, 125mM NaCl and 0.5% Tween-20) was used. SuperSignal West
Pico and Femto reagents (Pierce) were used to detect HRP-conjugated secondary
antibodies. The following antibodies were used for immunoblotting: LIG4
(Sigma (HPA001334); 1:5,000 dilution) and tubulin (Santa Cruz (A-6); 1:10,000).
The original immunoblot images can be found in Supplementary Fig. 9.
Plasmid recircularization assays. tdTomato-CreERT2-pcDNA3.1 plasmids were
linearized by EcoRI located between the promoter and the coding sequence.
CFP-pCMV plasmids were used as an internal control. Cells pretreated with
dimethylsulfoxide (vehicle control) or iCRT14 were co-transfected with linearized
tdTomato-CreERT2-pcDNA3.1 and CFP-pCMV (10:1 ratio). After 48 h, cells were
fixed with 4% paraformaldehyde and were analysed by FACS.
Statistical analysis. The Student’s t-test was used for comparisons of two samples.
P valueso0.05 were considered significant. Error bars indicate s.e.m. The number
of biological and experimental replicasZ3, otherwise mentioned in figure legends.
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